Suppression of in vivo tumor growth by the transfection of the interleukin-5 gene into colon tumor cells Yoshihiro MasudaSeiji MitaTakatoshi Ishiko Michio Ogawa Original Article Pages: 325 - 330
Pharmacokinetics of human-mouse chimeric anti-GD2 mAb ch14.18 in a phase I trial in neuroblastoma patients M. M. Uttenreuther-FischerC. S. HuangA. L. Yu Original Article Pages: 331 - 338
Specific antitumor activity of tumor-infiltrating lymphocytes expanded first in a culture with both anti-CD3 monoclonal antibody and activated B cells and then in a culture with interleukin-2 Koji TamadaMamoru HaradaKikuo Nomoto Original Article Pages: 339 - 347
Characterisation of the anti-bladder-cancer monoclonal antibody BLCA-8: Identification of its antigen as a neutral glycolipid Elizabeth A. KingsleyTeresa E. CarterPamela J. Russell Original Article Pages: 348 - 354
Restoration of interleukin-2 production in tumor-bearing rats through reducing tumor-derived transforming growth factor β by treatment with bleomycin Lan YuanYasuhiro KuramitsuMasuo Hosokawa Original Article Pages: 355 - 362
Low-dose-melphalan-induced up-regulation of type-1 cytokine expression in the s.c. tumor nodule of MOPC-315 tumor bearers and the role of interferon γ in the therapeutic outcome Leonid GorelikMargalit B. Mokyr Original Article Pages: 363 - 374
Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL) Lucio TentoriCarlo LeonettiEnzo Bonmassar Original Article Pages: 375 - 383
Protection against metastasis by immunization with an allogeneic lymphocyte antigen Kohji EgawaNaohiro SeoTomomi Tsukiyama Original Article Pages: 384 - 388
Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K E. YefenofI. GafanovitchE. Klein Original Article Pages: 389 - 396
